Access to Freestyle Libre is widening for Type 1 diabetes patients

Access to Freestyle Libre is widening for Type 1 diabetes patients

March 11, 2019

From 1st April 2019, community pharmacy teams may see an increase in prescriptions for Freestyle Libre sensors following a growth in funding which will allow access to flash glucose monitoring throughout the country.

In 2018, NHS England announced that there will be an end to the current variation patients in some parts of the country are facing in accessing Freestyle Libre. NHS England has now published guidance that sets out the eligibility criteria for flash glucose monitoring and the maximum amounts that CCGs will be reimbursed for the ongoing costs of flash glucose sensors.

Freestyle Libre sensors are listed as an Appliance in Part IXA of the Drug Tariff which can be dispensed against NHS prescriptions. The sensors can only be ordered directly from Abbott through their pharmacy ordering portal.

PSNC has a resource relating to dispensing appliances and includes FAQs you may find helpful.

 



Posted in:


More Latest News >

CPCS Toolkit published

The NHS Community Pharmacist Consultation Service (CPCS) will commence on 29th October 2019 and the Toolkit to support pharmacy teams to provide...